This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Other. Active years: 1988-1998.
Location History:
- Chicago, IL (US) (1988 - 1998)
- Providence, RI (US) (1998)
Company Filing History:
5 out of 834,453 Years Active: 1988-1998
Title: Innovations of Jacqueline Sagen
Introduction
Jacqueline Sagen is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of medical science, particularly in the area of opiate tolerance. With a total of 5 patents to her name, her work is paving the way for new treatments and therapies.
Latest Patents
Among her latest patents are groundbreaking methods aimed at addressing opiate tolerance. One of her notable inventions is titled "Preventing opiate tolerance by cellular implantation." This patent focuses on the use of CNS transplants, specifically adrenal medullary transplants, to reduce and prevent tolerance to opiates. Another significant patent is "Reversing opiate tolerance by cellular implantation," which provides a method for reversing tolerance to opiates through the implantation of adrenal medullary cells into the CNS.
Career Highlights
Jacqueline Sagen's career is marked by her innovative approach to solving complex medical issues. Her research has garnered attention for its potential to change the way opiate tolerance is managed in patients. Her dedication to advancing medical science is evident in her numerous patents and ongoing research efforts.
Collaborations
Jacqueline has collaborated with esteemed colleagues in her field, including George D. Pappas and Mark Perlow. These partnerships have further enriched her research and contributed to the development of her innovative patents.
Conclusion
Jacqueline Sagen's work exemplifies the spirit of innovation in the medical field. Her contributions to understanding and addressing opiate tolerance are significant and hold promise for future advancements in treatment.